Castle Biosciences 表示2026年营收展望为3.85亿至3.95亿美元，TissueCypher目标销量增长50%-52%（纳斯达克：CSTL）
· seekingalpha.com
Castle Biosciences 2026年第三季度财报：营收增长24%，上调指引，TissueCypher推动增长。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...